The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrufin Plc Regulatory News (TRU)

Share Price Information for Trufin Plc (TRU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 73.50
Bid: 72.00
Ask: 75.00
Change: 0.50 (0.68%)
Spread: 3.00 (4.167%)
Open: 73.00
High: 73.50
Low: 73.00
Prev. Close: 73.00
TRU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Share Awards under LTIP

28 Jul 2023 07:00

RNS Number : 4811H
TruFin PLC
28 July 2023
 

28 July 2023

TruFin plc("TruFin" or the "Company")

Grant of share awards under Long Term Incentive Plan

As referred to in TruFin's announcement on 22 June 2023, the Company announces that it has now adopted a new Long Term Incentive plan (the "LTIP"). The LTIP has been implemented to appropriately incentivise key individuals over the long term, driving retention and performance.

 

The Company's intention is to operate the LTIP as a four-year programme of awards, with awards vesting in four tranches from 31 December 2023 and each anniversary of that date until 31 December 2026.

 

Therefore, on 27 July 2023, the Company awarded the first three tranches of awards under the LTIP. These are in the form of options over a total of 3,116,667 Ordinary Shares (the "Options") to the Chief Executive Officer and other senior employees.

 

The Options will vest in three tranches from 31 December 2023 and the anniversaries of that date up to and including 31 December 2025. Save for the first tranche of Options that vest on 31 December 2023, vesting of the Options granted to James van den Bergh (CEO) and James Hussey (CFO) are subject to performance criteria set by the Remuneration Committee of the Company based on a share price performance metric. In addition to this metric, Options granted to subsidiary company CEOs are subject to subsidiary company financial performance metrics. The Options expire 10 years post grant date.

 

The Company's intention is to grant the fourth tranche of options in early 2024, following the announcement of the Company's results for the 2023 financial year, subject to the same performance metrics as the second and third tranches of the Options but with a vesting date of 31 December 2026 (the "Tranche 4 Options").

 

Details of the grants of Options and the proposed grant of Tranche 4 Options to PDMRs are set out below:

 

Name

Position

Options granted

Tranche 4 Options (not yet granted)

Tranche 1

Tranche 2

Tranche 3

Tranche 4

James van den Bergh

Chief Executive Officer

300,000

300,000

300,000

300,000

James Hussey

Chief Financial Officer

225,000

225,000

225,000

225,000

 

These awards are intended to align the incentives of the CEO, CFO and other senior employees with the Company's performance and outcomes for shareholders over the long term and to provide effective and attractive levels of reward to retain individuals who are key to the future success of the Company, based on delivering strong performance in a fair and proportionate manner.

 

Vesting will also normally be dependent on the continued employment of the participant within the Company's group. The awards are subject to market standard leaver, malus and clawback provisions.

 

The total four-year programme of awards comprising the Options and the Tranche 4 Options are intended to be up to 4,200,000 Ordinary Shares, representing 4.0 per cent. of the Company's current issued share capital. Following the grant of the four tranches, there will be total options outstanding over a total of 10,634,675 Ordinary Shares in the Company, representing 10.0 per cent. of the Company's current issued share capital.

 

The following notifications are intended to satisfy the Company's obligations under Article 19 of the UK Market Abuse Regulation.

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

James van den Bergh

James Hussey

2.

Reason for the Notification

a)

Position/status

Chief Executive Officer

Chief Financial Officer

b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

TruFin Plc

b)

LEI

213800C2QPZFECSRZ964

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares

Identification code

ISIN: JE00BYVWJZ03

b)

Nature of the transaction

Grant of options

c)

Price(s) and volume(s)

Price

Volume

Nil

900,000

Nil

675,000

d)

Aggregated information:

Aggregated volume

Price

Single transaction as in 4c) above

1,575,000

Nil

e)

Date of the transaction

27 July 2023

f)

Place of the transaction

Outside a trading venue

 

 

 

Enquiries:

TruFin plcJames van den Bergh, Chief Executive OfficerKam Bansil, Investor Relations

0203 743 13400777 922 9508

 

Liberum Capital Limited (Nominated Adviser and Corporate broker)Chris ClarkeEdward Thomas

Cara Murphy

0203 100 2000

About TruFin plc:

TruFin plc is the holding company of an operating group comprising four growth-focused technology businesses operating in niche markets: early payment provision, invoice finance, IFA finance and mobile games publishing. The Company was admitted to AIM in February 2018 and trades under the ticker symbol: TRU. More information is available on the Company website: www.TruFin.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHNKOBPOBKDKOB
Date   Source Headline
9th Jun 20207:00 amRNSNotice of Annual General Meeting Posting
1st Jun 20202:52 pmRNS2020 Annual General Meeting and Board Changes
15th May 20207:00 amRNSFinal Results For The Year Ended 31 December 2019
13th May 202011:05 amRNSHolding(s) in Company
13th May 20207:00 amRNSHolding(s) in Company
11th May 202010:43 amRNSHolding(s) in Company
29th Apr 202010:33 amRNSAppointment of a Non-Executive Director
24th Mar 20207:00 amRNSPre-Close Trading Update
20th Mar 20204:00 pmRNSStatement Regarding Satago
21st Feb 20207:00 amRNSVesting of JSOP Founder Awards
24th Dec 20197:00 amRNSResult of Tender Offer
23rd Dec 201910:26 amRNSGeneral Meeting Results
4th Dec 20197:00 amRNSProposed Tender Offer and Trading Update
8th Nov 20197:00 amRNSQ3 Trading Update
26th Sep 20194:33 pmRNSResults of Written Resolutions
13th Sep 20193:55 pmRNSStatement Regarding Closure of Arrowgrass
11th Sep 20194:21 pmRNSDirector/PDMR Shareholding
11th Sep 20197:00 amRNS2019 Interim Results and Company Updates
29th Jul 20197:00 amRNSRestructuring and Update
5th Jun 20197:00 amRNSResult of Tender Offer
4th Jun 20191:19 pmRNSResult of AGM
17th May 20197:00 amRNSNotice of Tender Offer and AGM
9th May 20197:00 amRNSDemerger Effective And DFC Holdings Admission
7th May 201911:46 amRNSGeneral Meeting Results & Completion Of Zopa Sale
3rd May 20195:30 pmRNSTruFin
24th Apr 20193:59 pmRNSDirector/PDMR Shareholding
17th Apr 20196:20 pmRNSResult of Placing
17th Apr 20192:44 pmRNSStrategic Update, Demerger of DFC and Zopa Sale
17th Apr 20192:41 pmRNSFinal Results for the year ended 31 December 2018
22nd Feb 201911:17 amRNSVesting of Share Incentive/Options for PDMRs
7th Dec 20184:05 pmRNSProgress Update
4th Dec 20187:00 amRNSZopa Banking Licence
29th Nov 20187:01 amRNSStrategy/Company/Ops Update
29th Nov 20187:00 amRNSChange of Adviser
14th Sep 20189:04 amRNSDirector/PDMR Shareholding
13th Sep 20187:00 amRNSHalf-year Report
6th Aug 20186:29 pmRNSAcquisition of Porge Ltd by Oxygen Finance Group
3rd Aug 20187:00 amRNSZopa Fundraising
13th Jul 20185:39 pmRNSDirector/PDMR Shareholding
13th Jul 20185:26 pmRNSDirector/PDMR Shareholding
19th Jun 201812:17 pmRNSResult of AGM
1st Jun 20186:30 pmRNSHolding(s) in Company
1st Jun 20184:00 pmRNSPosting of Annual Report and Notice of AGM
30th May 20187:00 amRNSDirector/PDMR Shareholding
30th May 20187:00 amRNSDirector/PDMR Shareholding
16th May 20187:00 amRNSFinal Results for the year ended 31 December 2017
23rd Feb 201810:59 amRNSDirector/PDMR Shareholding
21st Feb 20187:00 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.